DFF332 as a Single Agent and in Combination With Everolimus & Immuno-Oncology Agents in Advanced/Relapsed Renal Cancer & Other Malignancies
Novartis
Novartis
St. Jude Children's Research Hospital
Memorial Sloan Kettering Cancer Center
St. Jude Children's Research Hospital
University of California, San Francisco
Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
National Cancer Institute (NCI)
University of Florida
Sumitomo Pharma America, Inc.
SCRI Development Innovations, LLC
Five Prime Therapeutics, Inc.
Emory University
Celgene
Emory University
Merck Sharp & Dohme LLC
Masonic Cancer Center, University of Minnesota
University of Southern California
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
Children's Oncology Group
Yale University
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
European Organisation for Research and Treatment of Cancer - EORTC
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Pfizer
Case Comprehensive Cancer Center